FDA label 8a626fbe-4633-4ad0-9986-525b72f4d4bf

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
a359b471-4f88-4a75-a3c0-98c1a8e2aea4
SPL ID
8a626fbe-4633-4ad0-9986-525b72f4d4bf
Version
3
Effective date
2014-08-21
Source export date
2026-09-28
Source partition
2
Source file
https://download.open.fda.gov/drug/label/drug-label-0002-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/f7d2b6e3f8600cd856280ab55a9c6fa54a642647191d164f9d1110e89f3f4097/drug-label-0002-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:17:05

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS Do not give to children under 12 years of age. If pregnant or breast-feeding, ask a healthcare provider before use. Keep out of reach of children. If sleeplessness or nervous tension persists continuously for more than two weeks, a healthcare provider should be consulted. Insomnia may be a symptom of serious underlying medical illness. Due to the homeopathic nature of WellMind™ tablets a temporary worsening in symptoms (initial aggravation) may occur, but often resolves quickly. Allergic (hypersensitivity) skin reactions may occur in very rare cases. Do not use if known sensitivity to WellMind™ or any of its ingredients exists.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.